Advanced Relapsed or Refractory Germ Cell Tumours research hub

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

This study tests a new medicine called BI 3820768 for advanced germ cell, endometrial, or ovarian cancers. It aims to find a safe dose and see if it shrinks tumours. This medicine helps your immune system fight cancer.